Page 816 - ACCCN's Critical Care Nursing

I N D E X 793

Index

A activated clotting time (ACT) 300 pregnancy and 364
AAA see abdominal aortic aneurysm active exercises 111 proliferative phase of 363
AACN see American Association of Critical-Care activities, ICU follow-up clinics and 69–70 acute stroke, ED presentation and 594–596
Nurses ACTR see Australian Clinical Trial Registry acute tubular necrosis (ATN) 479, 484–486,
abdominal aortic aneurysm (AAA) 593 acute care nurse practitioners (ACNPs), research 485f, 783
abdominal compartment syndrome (ACS) vignette 13b acute-on-chronic liver failure (AoCLF) 517–518,
640–641, 783 acute coronary syndrome (ACS) 216, 592 783
abdominal symptom presentation, in ED cardiac rehabilitation 226–227 acute/severity of illness, measurement in
593–594 emotional response and 226 ICU 26
abdominal aortic aneurysm 593 management 221, 222f ADAPT see Australasian Donor Awareness
algorithm for 594f medications for 225, 225t Program Training
appendicitis 593–594 nursing management of 224–226 ADEs see adverse drug events
bowel obstruction 594 research vignette 247b ADH see antidiuretic hormone
ectopic pregnancy 594 support of patient and family 226 adolescents
abdominal trauma 639–643 symptom control of 225–226 developmental considerations in 685
in children 702 acute kidney injury (AKI) 479, 484–486, 783 see also children
signs of 641t acute liver failure (ALF) 517–518, 783 adrenal insufficiency 568
ABGs see arterial blood gases acute liver injury (ALI) 783 adult guardian 783
ablation therapies 285, 783 acute lung injury (ALI) 334–335, 362–364 advance directives 86, 783
abnormal automaticity 252 transfusion-related 363 advance practice nurses 20
Aboriginal people 783 see also acute respiratory distress syndrome advanced life support (ALS) 661–670, 661f, 783
communication with 169 acute myocardial infarction (AMI) 216 airway management 663
contemporary and diversity of 168 acute organ dysfunction 567t for infants and children 662f
death and dying issues 169–170 acute phase proteins 783 medication administration during 663–666,
health and health beliefs view 168 acute physiology and chronic health evaluation 664t, 667t–668t
healthcare workers 169 (APACHE) score 26, 570, 783 pregnancy and 733
importance of family, community and acute rejection, of heart transplantation 313, rhythm 663
land 168–169 313t, 318t pulseless electrical activity 663, 665t
working with 167t, 168–170 acute renal failure (ARF) 479, 783 pulseless ventricular tachycardia 663
abruptio placentae 721 acute kidney injury 484–486 ventricular fibrillation 663
absolute humidity 389 acute tubular necrosis 484–486, 485f adverse drug events (ADEs) 42
A/C see assist control classification of 483–486 reduction of 43
ACCCN see Australian College of Critical Care clinical assessment of 486 adverse event (AE) 42
Nurses clinical management of 487–488 advocacy
accelerated idioventricular rhythm (AIVR) 259, insult reduction 487–488 nursing 87–88
259f consensus definition 486–487 patient 86
access catheters 783 diagnosis of 486 AE see adverse event
site 783 intrarenal (intrinsic) causes of 484 AEDs see automatic external defibrillators
vascular 789 glomerulonephritis 484 AFE see amniotic fluid embolism
ACE see angiotensin-converting enzyme nephrotoxicity 484 afferent limb, of RRS 50–51
inhibitors vascular insufficiency 484 afferent neurons 416f
acetylcholine 416 nutrition and 488 afterload 186
ACHS see Australian Council on Healthcare pathophysiology of 483–486 PVR 202–203
Standards indicators post heart transplantation 315, 318t SVR 202
acid, corrosive, exposure to 603–604, 603t postrenal causes of 484 Agency for Healthcare Research and Quality
acid-base control 333 prerenal causes of 483–484 (AHRQ) 43
renal system and 483, 483f RIFLE criteria 486–487, 487f AGREE see Appraisal of Guidelines for Research
ACNPs see acute care nurse practitioners RRR for 488–490, 488b and Evaluation
acquired weakness see intensive care unit- acute respiratory distress syndrome AHMAC see Australian Health Ministers
acquired weakness (ARDS) 334–335, 783 Advisory Council
ACS see abdominal compartment syndrome; aetiology of 363, 363t AHRQ see Agency for Healthcare Research and
acute coronary syndrome clinical manifestations of 363 Quality
ACT see activated clotting time assessment 363 AIMS-ICU see Australian Incident Monitoring
actigraphy 146, 783 collaborative practice 364 Study-Intensive Care Unit
actin filaments 183, 183f medications 364 airborne precautions 119, 119t
action potential 183–184, 184f prone positioning 364 airway
generation of 417t ventilation strategies 364 adult 682f
diagnosis of 363 in children 682f
edematous phase of 363 disease of lower see lower airway disease
elderly and 364 obstruction of see upper airway obstruction
Page numbers followed by ‘f’ indicate figures, ‘t’ fibrotic phase of 363 support 383
indicate tables, and ‘b’ indicate boxes. pathophysiology of 363 in ALS 663 793